Trump speaks and gestures is in focus behind the blurry foreground of red, white, and mainly blue stage decoration -- coverage from STAT
Chip Somodevilla/Getty Images

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and some bad news for the health care industry. 

It’s unclear which side of the Republican wave that brought President-elect Trump to power will win out on health care policy — the pro-business, anti-regulation, traditional conservative approach that favors lower taxes, or the populist wing of the party harnessed by Robert F. Kennedy Jr. that is distrustful of institutions and eager to blame large corporations, including major pharmaceutical companies, for Americans’ poor health.

advertisement

Insurers could be squeezed if Democrat-passed subsidies to Affordable Care Act plans expire, driving people out of the market. And if Republicans turn to cuts to Medicaid to fund their other priorities, hospitals could get saddled with more uninsured patients. 

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe